InveniAI

Developing Patient Solutions at Unprecedented Scale and Speed 🚀

InveniAI is a global leader in pioneering the application of artificial intelligence. The company provides Big Data & BI services to its clients, enabling them to quickly search for transformational treatment options at unprecedented speed and scale. InveniAI's AlphaMeld technology seamlessly integrates complex scientific, medical, chemical, and biological landscapes, allowing domain experts and drug developers to rapidly prioritize biological targets and modalities with the most appropriate disease indication(s) while maximizing both safety and efficacy. This innovative approach enables companies to drive a pipeline of therapies addressing chronic inflammatory diseases of the gut based on high unmet medical need, while maximizing localized efficacy and reducing systemic side-effects compared with the current standard of care. InveniAI's services benefit clients by providing them with access to cutting-edge AI technology, enabling them to make data-driven decisions and stay ahead of the competition.